
Examining the Potential Price Growth of Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on
Dyne Therapeutics Inc’s recent filing unveils that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Dyne Therapeutics Inc’s filing revealed that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on Sep
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on
In a filing, Dyne Therapeutics Inc revealed its Chief Commercial Officer Friedl-Naderer Johanna unloaded Company’s shares for reported $11863.0 on
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John acquired Company’s shares for reported $0.91 million
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John acquired Company’s shares for reported $0.91 million
Dyne Therapeutics Inc’s filing revealed that its CEO & President Cox John acquired Company’s shares for reported $0.91 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dyne Therapeutics